Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by TheCryptoKingon Jan 04, 2018 12:18pm

33 Views

Post# 27280878

RE:bids are stacking

Sounds like v.SAH (at just 3.5 cents !) is going into the crypto-currency space. v.SAH has $10.7 million cash in its treasury and zero debt. More cash in v.SAH's treasury than its market-cap ! Very strong Chinese (billionaires ) financial backers of v.SAH

Bullboard Posts

Two micro-cap stocks with strong fundamentals